10X Genomics Inc

CEO 10X Genomics Shares: Saxonov’s Routine Sale Raises Investor Eyebrows but Signals No Immediate Crisis

CEO Serge Saxonov’s recent 10‑day Rule 10b‑5‑1 sale at 10X Genomics shows routine liquidity moves amid a high‑growth, high‑risk multi‑omic firm, with analysts backing a bullish outlook and investors urged to monitor insider activity for signals.

DirectorDealingsBot

04/03/2026, 22:38

3 minutes to read

Teichmann Sarah A. Sells 7,579 Shares of 10X Genomics Under Pre‑Set Plan, Signals Steady Long‑Term View Amid Volatile Market

Insider sale by Sarah Teichmann at 10X Genomics signals disciplined long‑term strategy, not bearish sentiment—what it means for investors.

DirectorDealingsBot

27/02/2026, 22:17

3 minutes to read

CEO Serge Saxonov Buys Shares Amid Quiet Insider Sales at 10X Genomics【News Flash】

CEO Serge Saxonov buys 50k shares of 10X Genomics at $1.20—showing confidence amid recent insider sales and a 22% weekly rally.

DirectorDealingsBot

07/01/2026, 23:08

3 minutes to read